Results 121 to 130 of about 24,661 (210)

Machine Learning Based Multi-Parameter Modeling for Prediction of Post-Inflammatory Lung Changes. [PDF]

Diagnostics (Basel)
Widmann G, Luger AK, Sonnweber T, Schwabl C, Cima K, Gerstner AK, Pizzini A, Sahanic S, Boehm A, Coen M, Wöll E, Weiss G, Kirchmair R, Gruber L, Feuchtner GM, Tancevski I, Löffler-Ragg J, Tymoszuk P.   +17 more
europepmc   +1 more source

Rituximab in systemic sclerosis-associated interstitial lung disease: A systematic review and meta-analysis. [PDF]

Sci Prog
Jang JH, Her M, Oh JH, Park JH, Jung SY, Ko J, Lee JH.   +6 more
europepmc   +1 more source

The Predictive Role of C-Reactive Protein, Leukocyte Cell Count, and Soluble Urokinase Plasminogen Activator Receptor for Pulmonary Sequelae in Hospitalized COVID-19 Survivors: A Prospective Single-Center Cohort Study. [PDF]

J Clin Med
Altintas I, Kallemose T, Lindstrøm MB, Parvaiz I, Rokkedal I, Rasmussen LJ, Iversen KK, Eugen-Olsen J, Iversen KK, Hansen EF, Ulrik CS, Nehlin JO, Andersen O.   +12 more
europepmc   +1 more source

Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective study. [PDF]

Sci Rep
Denis A, Henket M, Giltay L, Gillet H, Creuen X, Frix AN, Gester F, Louis R, Guiot J.   +8 more
europepmc   +1 more source

Haemodynamics and post-exercise recovery response in COPD-PH and ILD-PH: An appraisal. [PDF]

Lung India
Sengupta S, Bhattacharyya P, De A, Karmakar S, Chakraborty W, Saha D.   +5 more
europepmc   +1 more source

Significance of measuring the severity of emphysema, in combination with spirometry, on the risk evaluation of patients undergoing major lung resection for cancer†. [PDF]

Interdiscip Cardiovasc Thorac Surg
Suzuki S, Harada-Takeda A, Morizono S, Takumi K, Umehara T, Kamimura G, Aoki M, Nagata T, Ueda K.   +8 more
europepmc   +1 more source

A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis. [PDF]

Rheumatology (Oxford)
Bjørkekjær HJ, Bruni C, Broch K, Brunborg C, Carreira PE, Airò P, Simeón-Aznar CP, Truchetet ME, Giollo A, Balbir-Gurman A, Martin M, Denton CP, Gabrielli A, Del Galdo F, Vonk MC, Fretheim H, Bitter H, Midtvedt Ø, Andreassen A, Høie S, Tanaka Y, Riemekasten G, Müller-Ladner U, Matucci-Cerinic M, Castellví I, Siegert E, Hachulla E, Molberg Ø, Distler O, Hoffmann-Vold AM, EUSTAR Collaborators .   +30 more
europepmc   +1 more source

Clinical significance of miR-6515-5p in predicting diagnosis and prognosis for acute respiratory distress syndrome suffering from pulmonary fibrosis. [PDF]

Hereditas
Huang X, Xu P, Long G, Huang F, Zhang Q, Yang X, Sun H, Ji C, Liu W.   +8 more
europepmc   +1 more source

A comparison of pulmonary function pre and post mild SARS-CoV-2 infection among healthy adults. [PDF]

BMC Pulm Med
Taib RR, Kozlov Y, Ekshtein A, Gordon B, Wand O, Ben-Ari O.   +5 more
europepmc   +1 more source

Real-world insights into safety, tolerability, and predictive factors of adverse drug reactions in treating idiopathic pulmonary fibrosis with pirfenidone and nintedanib. [PDF]

Ther Adv Drug Saf
Provenzani A, Leonardi Vinci D, Alaimo M, Di Maria S, Tuzzolino F, Floridia G, Di Stefano R, Carollo A, Callari A, Polidori P, Vitulo P.   +10 more
europepmc   +1 more source